Home Healthcare Biotechnology Viral Vaccines Market

Viral Vaccines Market Size, Share & Trends Analysis Report By Types (Live attenuated vaccines, Inactivated vaccines, Sub-Unit viral vaccines), By Consumer groups (Pediatric, Adults), By Disease Indication (Cancer, Influenza, Human Papilloma Virus, Rota Virus, Poliomyelitis, Hepatitis, Others), By Route of Administration (Parenteral, Oral) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR1417DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Viral Vaccines Market, By Types 2022-2034 (USD MILLION/ Units)
    1. Live attenuated vaccines
    2. Inactivated vaccines
    3. Sub-Unit viral vaccines
  2. Viral Vaccines Market, By Consumer groups 2022-2034 (USD MILLION/ Units)
    1. Pediatric
    2. Adults
  3. Viral Vaccines Market, By Disease Indication 2022-2034 (USD MILLION/ Units)
    1. Cancer
    2. Influenza
    3. Human Papilloma Virus
    4. Rota Virus
    5. Poliomyelitis
    6. Hepatitis
    7. Others
  4. Viral Vaccines Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Parenteral
    2. Oral
  5. Regional Viral Vaccines Market
    1. North America
      1. North America Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
        1. Live attenuated vaccines
        2. Inactivated vaccines
        3. Sub-Unit viral vaccines
      2. North America Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adults
      3. North America Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Influenza
        3. Human Papilloma Virus
        4. Rota Virus
        5. Poliomyelitis
        6. Hepatitis
        7. Others
      4. North America Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
      5. U.S. Viral Vaccines Market
        1. U.S. Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. U.S. Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. U.S. Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. U.S. Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      6. Canada Viral Vaccines Market
        1. Canada Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Canada Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Canada Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Canada Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
    2. Europe
      1. Europe Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
        1. Live attenuated vaccines
        2. Inactivated vaccines
        3. Sub-Unit viral vaccines
      2. Europe Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adults
      3. Europe Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Influenza
        3. Human Papilloma Virus
        4. Rota Virus
        5. Poliomyelitis
        6. Hepatitis
        7. Others
      4. Europe Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
      5. U.K. Viral Vaccines Market
        1. U.K. Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. U.K. Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. U.K. Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. U.K. Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      6. Germany Viral Vaccines Market
        1. Germany Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Germany Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Germany Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Germany Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      7. France Viral Vaccines Market
        1. France Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. France Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. France Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. France Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      8. Spain Viral Vaccines Market
        1. Spain Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Spain Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Spain Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Spain Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      9. Italy Viral Vaccines Market
        1. Italy Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Italy Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Italy Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Italy Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      10. Russia Viral Vaccines Market
        1. Russia Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Russia Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Russia Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Russia Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      11. Nordic Viral Vaccines Market
        1. Nordic Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Nordic Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Nordic Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Nordic Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      12. Benelux Viral Vaccines Market
        1. Benelux Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Benelux Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Benelux Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Benelux Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      13. Rest of Europe Viral Vaccines Market
        1. Rest of Europe Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Rest of Europe Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Rest of Europe Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Rest of Europe Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
    3. APAC
      1. APAC Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
        1. Live attenuated vaccines
        2. Inactivated vaccines
        3. Sub-Unit viral vaccines
      2. APAC Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adults
      3. APAC Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Influenza
        3. Human Papilloma Virus
        4. Rota Virus
        5. Poliomyelitis
        6. Hepatitis
        7. Others
      4. APAC Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
      5. China Viral Vaccines Market
        1. China Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. China Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. China Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. China Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      6. Korea Viral Vaccines Market
        1. Korea Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Korea Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Korea Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Korea Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      7. Japan Viral Vaccines Market
        1. Japan Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Japan Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Japan Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Japan Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      8. India Viral Vaccines Market
        1. India Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. India Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. India Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. India Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      9. Australia Viral Vaccines Market
        1. Australia Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Australia Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Australia Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Australia Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      10. Singapore Viral Vaccines Market
        1. Singapore Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Singapore Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Singapore Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Singapore Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      11. Taiwan Viral Vaccines Market
        1. Taiwan Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Taiwan Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Taiwan Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Taiwan Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      12. South East Asia Viral Vaccines Market
        1. South East Asia Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. South East Asia Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. South East Asia Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. South East Asia Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      13. Rest of Asia-Pacific Viral Vaccines Market
        1. Rest of Asia-Pacific Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Rest of Asia-Pacific Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Rest of Asia-Pacific Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Rest of Asia-Pacific Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
    4. Middle East and Africa
      1. Middle East and Africa Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
        1. Live attenuated vaccines
        2. Inactivated vaccines
        3. Sub-Unit viral vaccines
      2. Middle East and Africa Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adults
      3. Middle East and Africa Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Influenza
        3. Human Papilloma Virus
        4. Rota Virus
        5. Poliomyelitis
        6. Hepatitis
        7. Others
      4. Middle East and Africa Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
      5. UAE Viral Vaccines Market
        1. UAE Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. UAE Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. UAE Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. UAE Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      6. Turkey Viral Vaccines Market
        1. Turkey Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Turkey Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Turkey Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Turkey Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      7. Saudi Arabia Viral Vaccines Market
        1. Saudi Arabia Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Saudi Arabia Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Saudi Arabia Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Saudi Arabia Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      8. South Africa Viral Vaccines Market
        1. South Africa Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. South Africa Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. South Africa Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. South Africa Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      9. Egypt Viral Vaccines Market
        1. Egypt Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Egypt Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Egypt Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Egypt Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      10. Nigeria Viral Vaccines Market
        1. Nigeria Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Nigeria Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Nigeria Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Nigeria Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      11. Rest of MEA Viral Vaccines Market
        1. Rest of MEA Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Rest of MEA Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Rest of MEA Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Rest of MEA Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
    5. LATAM
      1. LATAM Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
        1. Live attenuated vaccines
        2. Inactivated vaccines
        3. Sub-Unit viral vaccines
      2. LATAM Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adults
      3. LATAM Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Influenza
        3. Human Papilloma Virus
        4. Rota Virus
        5. Poliomyelitis
        6. Hepatitis
        7. Others
      4. LATAM Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
      5. Brazil Viral Vaccines Market
        1. Brazil Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Brazil Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Brazil Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Brazil Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      6. Mexico Viral Vaccines Market
        1. Mexico Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Mexico Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Mexico Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Mexico Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      7. Argentina Viral Vaccines Market
        1. Argentina Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Argentina Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Argentina Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Argentina Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      8. Chile Viral Vaccines Market
        1. Chile Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Chile Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Chile Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Chile Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      9. Colombia Viral Vaccines Market
        1. Colombia Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Colombia Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Colombia Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Colombia Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
      10. Rest of LATAM Viral Vaccines Market
        1. Rest of LATAM Viral Vaccines Market By Types 2022-2034 (USD MILLION/ Units)
          1. Live attenuated vaccines
          2. Inactivated vaccines
          3. Sub-Unit viral vaccines
        2. Rest of LATAM Viral Vaccines Market By Consumer groups 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adults
        3. Rest of LATAM Viral Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Influenza
          3. Human Papilloma Virus
          4. Rota Virus
          5. Poliomyelitis
          6. Hepatitis
          7. Others
        4. Rest of LATAM Viral Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.